Discovery science

View all stories
article thumbnail

Harnessing tech to eliminate distance in a virtual world

An award-winning program has been key to our continued success despite limitations imposed by the COVID-19 pandemic

article thumbnail

Safeguarding the environment through green chemistry

When a manufacturing process doesn’t meet our standards, we build an award-winning, planet-friendly one

article thumbnail

Your questions answered: How Merck is responding to the COVID-19 pandemic

article thumbnail

Our commitment to HIV treatments and prevention through the years

We continue to work at the forefront of the fight against HIV

article thumbnail

This scientist helps translate inventions into vaccines to protect public health

Beth-Ann Coller, executive director, global clinical development, knows how disease outbreaks underscore the importance of vaccines

article thumbnail

Women in science? Absolutely.

Strong career paths and cutting-edge science draw more women to our small molecule process R&D team

article thumbnail

No matter rain, nor snow…

article thumbnail

When work hits close to home

For Chris Hinson, one of our colleagues, Merck’s commitment to making our medicines available to patients is very personal

article thumbnail

When patients are in need, we answer the call

Merck’s Board of Directors approves expansion of our plant in Durham, North Carolina, to help patients

article thumbnail

Over 30 Years: The Mectizan® Donation Program

article thumbnail

Merck scientists probe how our bodies' bugs impact immunity and disease

Our researchers are pioneering new ways to research and understand the biology of new diseases by looking inside the human gut

article thumbnail

Experts meet to discuss health care innovations during COVID

Merck’s chief patient officer, Julie Gerberding, joins the Fortune Global Forum to discuss breakthrough innovations in health care

article thumbnail

Vaccines aren’t virtual

The importance of childhood well visits to prevent certain infectious diseases during the pandemic - by Nick Kartsonis, SVP clinical research, vaccines and infectious disease

article thumbnail

Our new London Discovery Research Center site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

article thumbnail

No patient left behind in our clinical trials

We’re here for patients when they need us most

article thumbnail

If you build it (in 3D), they will come

Innovating with the power of 3D printing

article thumbnail

“Pride and honor”: Meet the Army microbiologist and Merck employee fighting COVID-19

article thumbnail

Merck tackles epidemics and pandemics: an illustrated history

article thumbnail

Clinical trials bring our medicines and vaccines to life

We appreciate all who have contributed to our clinical research

article thumbnail

Remembering Arnold Demain, one of our giants

A pioneering research microbiologist for our company leaves behind an impressive legacy.

article thumbnail

Merck joins the World Cancer Day movement to push for progress

Cancer is one of the most significant health challenges of our time – cutting lives too short for far too many people.

article thumbnail

Podcast: How Merck is looking at past epidemics and science to respond to the coronavirus outbreak

article thumbnail

Antimicrobial resistance: a problem without a simple answer

A Point of View by Joan R. Butterton, M.D., associate vice president, clinical research, infectious diseases

article thumbnail

The Vaccine Pioneers

article thumbnail

Vaccines: our history, our legacy

Merck and its legacy companies have been working to discover and develop vaccines for more than a century.